PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
Auto Draft
Auto Draft
Elrig
Auto Draft
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper
news

Putting the Technicals Into Perspective For Sino Biopharmaceutical ADR (SBHMY)

Investors have placed Sino Biopharmaceutical ADR (SBHMY) shares on watch as the Aroon Up indicator has moved above 70, indicating that there is strong upward momentum...
Continue Reading →
news

Takeda to Acquire Shire for $62 Billion

Takeda Pharmaceutical Company Limited announced on May 8, 2018 that it has reached agreement on the terms of an offer to acquire Shire plc in a deal valued at $62 bil...
Continue Reading →
news

Lilly strikes $1.6B deal to buy I-O player Armo Biosciences

Eli Lilly and Co. said it will buy Armo Biosciences Inc. for about $1.6 billion, in an all-cash transaction intended to bolster its immuno-oncology program through th...
Continue Reading →
news

Fully Supporting Customer Needs for Biologics Development and Manufacturing

Over the past seven years, Samsung BioLogics has constructed three state-of-the-art production facilities offering end-to-end integrated services to support the rapid...
Continue Reading →
news

Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development

Abcam, a global leader in the supply of life science research tools, today signed a Memorandum of Understanding (MoU) with Shuwen Biotech, a leading player in the dev...
Continue Reading →
news

Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy

Celonic AG, the Swiss biologics contract development and manufacturing organization, has appointed Soenke Brunswieck as Vice President Cell & Gene Therapy to esta...
Continue Reading →
news

Achieving Large-Scale Cell and Gene Therapy Manufacturing

Initial clinical successes with cell and gene therapies have driven significant investment in these next-generation technologies by both large bio/pharma companies an...
Continue Reading →
news

The Swiss Biotech Association Honors Major Industry Achievements with Swiss Biotech Success Stories

On the occasion of its 20th anniversary, the Swiss Biotech Association launches Swiss Biotech Success Stories in recognition of the industry’s many accomplishments. S...
Continue Reading →
news

Medical AI startup Synyi raises $15.7 M

Synyi will use the fund to develop medical natural language processing, medical data governance and machine learning. Venture capital firm GGV Capital has led a RMB...
Continue Reading →
news

Korea to invest $33.4M in medical AI system

The ministry plans to carry out this medical artificial intelligence project over the course of three years. The South Korean government plans to invest 35.7 billi...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC